RESEARCH TRIANGLE PARK, N.C., Sept. 30 /PRNewswire/ -- Quintiles
Transnational Corp. today announced the completion of the previously announced
agreement with Aptuit, Inc., to enter a strategic partnership.
Aptuit has acquired three Quintiles business units - Preclinical Services,
Pharmaceutical Sciences and Clinical Trial Supplies - for approximately $125
million. The companies have signed a two-year commercial agreement
establishing arrangements to make these early development services available
through this agreement. The transaction also will enhance Quintiles' cash
position while allowing greater focus on core clinical services and clinical
support services.
The three Quintiles business units employ about 1,400 people, primarily in
Kansas City, Mo.; Mt. Laurel, N.J.; Edinburgh, Scotland; and Singapore.
Aptuit plans to reorganize the units into three global business lines:
Preclinical Technologies, Pharmaceutical Sciences and Packaging & Logistics.
Quintiles helps improve healthcare worldwide by providing a broad range of
professional services, information and partnering solutions to the
pharmaceutical, biotechnology and healthcare industries. Headquartered near
Research Triangle Park, North Carolina, Quintiles has 16,000 employees,
offices in 50 countries and is the world's leading pharmaceutical services
organization. For more information visit the company's Web site at
http://www.quintiles.com.
Information in this press release contains "forward-looking statements."
These statements involve risks and uncertainties that could cause actual
results to differ materially, including, without limitation, the ability of
the parties to operate under the alliance. Additional factors that could
cause actual results to differ materially are discussed in Quintiles' recent
filings with the Securities and Exchange Commission, including but not limited
to its annual report on Form 10-K, its quarterly report on Form 10-Q and its
current reports on Form 8-K.
SOURCE Quintiles Transnational Corp.
 back to top
Related links:
http://www.quintiles.com
CONTACT:
Dick Jones, Media Relations, +1-919-998-2091,
or media.info@quintiles.com, or Greg Connors, Investor Relations,
+1-919-998-2000, or invest@quintiles.com, both of Quintiles
Transnational Corp.
|
